
Available to mentor

Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan and serves as the Interim Director of the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.
Dr. Adler's clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association's headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.
-
Adaptive LeadershipUniversity of Michigan, United states, 2024
-
Advanced Improvement Methods (AIM), Center for Health Care QualityCincinnati Children's Hospital Medical Center, Cincinnati, 2015
-
Linkage Leadership AcademyUniversity of Michigan, Ann Arbor, 2015
-
Pediatric gastroenterology FellowshipC. S. Mott Children's Hospital, Ann Arbor, 2008
-
Pediatric ResidencyBoston Medical Center, Boston, 1997
-
MScHorace H. Rackham School of Graduate Studies, University of Michigan, Ann Arbor, 2009
-
MDUniversity of South Florida College of Medicine, 4202 E Fowler Ave, 1994
-
BSUniversity of Florida, Gainesville, 1990
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Constant BD, Adler J, Gold BD, Dotson J, Lightdale JR, Scott F, Saeed S, Kim S, Moses J, de Zoeten EF, Mirea L, Ritchey A, Pasternak B. JPGN Reports,Journal ArticleNational perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
DOI:10.1002/jpr3.70004 -
Patzer RE, Buford J, Urbanski M, McPherson L, Paul S, Di M, Harding JL, Katz-Greenberg G, Rossi A, Anand PM, Reeves-Daniel A, Jones H, Mulloy L, Pastan SO, Southeastern Kidney Transplant Coalition . Clin J Am Soc Nephrol, 2024 Dec 13; 20 (2): 256 - 266.Journal ArticleReducing Disparities in Access to Kidney Transplantation Regional Study: A Randomized Trial in the Southeastern United States.
DOI:10.2215/CJN.0000000586 PMID: 39671258 -
Dillman JR, Tkach JA, Fletcher JG, Bruining DH, Lu A, Kugathasan S, Alazraki AL, Knight-Scott J, Stidham RW, Adler J, Minar P, Trapnell BC, Bonkowski EL, Jurrell H, Lopez-Nunez O, Collins MH, Swanson SD, Fei L, Qian L, Towbin AJ, Kocaoglu M, Anton CG, Imbus RA, Dudley JA, Denson LA. Inflamm Bowel Dis, 2025 Jan 24;Journal ArticleCirculating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
DOI:10.1093/ibd/izae319 PMID: 39853252 -
Adler J, Gadepalli S, group BS. Journal of Crohn's and Colitis, 2025 Jan 22; 19 (Supplement_1): i1507 - i1508.Journal ArticleP0781 Perianal lesions present at paediatric Crohn’s disease diagnosis require early treatment with tumour necrosis factor antagonist to reduce high risk of perianal fistulising complications: a post-hoc analysis of a prospective, multicentre study
DOI:10.1093/ecco-jcc/jjae190.0955 -
Gadepalli S, Adler J, group BS. Journal of Crohn's and Colitis, 2025 Jan 22; 19 (Supplement_1): i1948 - i1949.Journal ArticleP1057 Early use of tumour necrosis factor antagonist for treatment of paediatric Crohn’s disease decreases perianal fistula development: a post-hoc analysis of a prospective, multicentre study
DOI:10.1093/ecco-jcc/jjae190.1231 -
Mallick-Searle T, Adler JA. J Pain Res, 2024 17: 1005 - 1028.Journal ArticleUpdate on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.
DOI:10.2147/JPR.S442595 PMID: 38505500 -
Lind M, R Cowan H, Adler JM, McAdams DP. J Pers Assess, 2024 Nov 15; 1 - 14.Journal ArticleDevelopment and Validation of the Narrative Identity Self-Evaluation Scale (NISE).
DOI:10.1080/00223891.2024.2425663 PMID: 39546387 -
Adler JM, Schwaba T. Am Psychol, 2024 Nov; 79 (8): 1227 - 1240.Journal ArticleBeyond "post," "traumatic," "growth," and prediction in research on posttraumatic growth.
DOI:10.1037/amp0001398 PMID: 39531718


